| Financial Year |
March 31 2023 |
| Monetary Funds |
692,483,968.65 |
| Held-for-trading Financial Assets |
552,772,500.00 |
| Notes Receivable |
29,300,000.00 |
| Accounts Receivable |
50,315,496.96 |
| Advances to Suppliers |
6,271,378.24 |
| Other Receivables |
5,499,553.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
104,984,830.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,757,994.85 |
| Total Current Assets |
1,463,603,011.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
273,021,093.59 |
| Investment Properties |
4,271,554.88 |
| Fixed Assetes |
104,258,737.30 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,659,637.98 |
| R&D expenses |
-- |
| Goodwill |
909,348,542.06 |
| Long-Term Deferred and Prepaid Expenses |
3,923,438.93 |
| Deferred Income Tax Assets |
10,419,365.90 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,318,319,930.60 |
| Total Assets |
2,781,922,942.38 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,333,552.89 |
| Accounts Received In Advance |
1,301,348.00 |
| Employee Compensation Payable |
21,483,339.42 |
| Taxes Payable |
6,162,158.29 |
| Interest Payable |
-- |
| Dividend Payable |
1,088,741.90 |
| Other payables |
12,667,512.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,737,348.45 |
| Other Current Liabilities |
463,683.76 |
| Sub-Total of Current Liabilities |
84,939,577.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,943,058.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,010,127.68 |
| Total Liabilities |
91,949,705.46 |
| Paid-In Capital(Or Share Stock) |
440,449,035.00 |
| Capital Surplus |
1,435,331,014.02 |
| Surplus Reserve |
205,175,994.59 |
| LESS:Treasury Stock |
20,921,636.01 |
| Undistributed Profits |
629,938,829.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,689,973,236.92 |
| Owner's Equity（Stockholder's Equity） |
2,689,973,236.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,781,922,942.38 |
